165 related articles for article (PubMed ID: 9009147)
1. Extreme N terminus of E1A oncoprotein specifically associates with a new set of cellular proteins.
Sang N; Giordano A
J Cell Physiol; 1997 Feb; 170(2):182-91. PubMed ID: 9009147
[TBL] [Abstract][Full Text] [Related]
2. Transactivation of the human cdc2 promoter by adenovirus E1A in cycling cells is mediated by induction of a 110-kDa CCAAT-box-binding factor.
Tanimoto A; Chen H; Kao CY; Moran E; Sasaguri Y; Padmanabhan R
Oncogene; 1998 Dec; 17(24):3103-14. PubMed ID: 9872326
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
Somasundaram K; El-Deiry WS
Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
[TBL] [Abstract][Full Text] [Related]
5. Dual action of the adenovirus E1A 243R oncoprotein on the human proliferating cell nuclear antigen promoter: repression of transcriptional activation by p53.
Kannabiran C; Morris GF; Mathews MB
Oncogene; 1999 Dec; 18(54):7825-33. PubMed ID: 10618724
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
[TBL] [Abstract][Full Text] [Related]
7. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity.
Sang N; Avantaggiati ML; Giordano A
J Cell Biochem; 1997 Sep; 66(3):277-85. PubMed ID: 9257185
[TBL] [Abstract][Full Text] [Related]
8. Mapping of adenovirus 5 E1A domains responsible for suppression of neu-mediated transformation via transcriptional repression of neu.
Chen H; Yu D; Chinnadurai G; Karunagaran D; Hung MC
Oncogene; 1997 Apr; 14(16):1965-71. PubMed ID: 9150363
[TBL] [Abstract][Full Text] [Related]
9. E1A modulates phosphorylation of p130 and p107 by differentially regulating the activity of G1/S cyclin/CDK complexes.
Parreño M; Garriga J; Limón A; Albrecht JH; Graña X
Oncogene; 2001 Aug; 20(35):4793-806. PubMed ID: 11521191
[TBL] [Abstract][Full Text] [Related]
10. Differential activation of cyclin and cyclin-dependent kinase genes by adenovirus E1A12S cDNA product.
Ishii T; Shimizu M; Kanayama Y; Nakada S; Nojima H; Oda K
Exp Cell Res; 1993 Oct; 208(2):407-14. PubMed ID: 8375470
[TBL] [Abstract][Full Text] [Related]
11. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor.
Goubin F; Ducommun B
Oncogene; 1995 Jun; 10(12):2281-7. PubMed ID: 7784076
[TBL] [Abstract][Full Text] [Related]
12. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.
Yang XJ; Ogryzko VV; Nishikawa J; Howard BH; Nakatani Y
Nature; 1996 Jul; 382(6589):319-24. PubMed ID: 8684459
[TBL] [Abstract][Full Text] [Related]
13. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
14. [Transfection with the E1A and E1B-19kDa oncogenes does not prevent rat embryo fibroblasts from cell cycle arrest after gamma-radiation].
Bulavin DV; Tararova ND; Brichkina AI; Aksenova ND; Pospelov VA; Pospelova TV
Mol Biol (Mosk); 2002; 36(1):58-65. PubMed ID: 11862714
[TBL] [Abstract][Full Text] [Related]
15. Expression of a novel form of p21Cip1/Waf1 in UV-irradiated and transformed cells.
Poon RY; Hunter T
Oncogene; 1998 Mar; 16(10):1333-43. PubMed ID: 9546435
[TBL] [Abstract][Full Text] [Related]
16. Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase.
Tsai LH; Harlow E; Meyerson M
Nature; 1991 Sep; 353(6340):174-7. PubMed ID: 1653904
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRb and disrupt pRb-E2F complexes.
Mal A; Piotrkowski A; Harter ML
J Virol; 1996 May; 70(5):2911-21. PubMed ID: 8627766
[TBL] [Abstract][Full Text] [Related]
18. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
[TBL] [Abstract][Full Text] [Related]
19. Identification of distinct roles for separate E1A domains in disruption of E2F complexes.
Ikeda MA; Nevins JR
Mol Cell Biol; 1993 Nov; 13(11):7029-35. PubMed ID: 8413292
[TBL] [Abstract][Full Text] [Related]
20. A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding.
Sandmöller A; Meents H; Arnold HH
Mol Cell Biol; 1996 Oct; 16(10):5846-56. PubMed ID: 8816499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
